Site-Specific Multi-Functionalization of the Carrier Protein CRM₁₉₇ by Disulfide Rebridging for Conjugate Vaccine...

Area of Science:

• Biotechnology
• Vaccinology
• Protein Chemistry

Background:

• Conjugation of antigens to carrier proteins like CRM197 is a cornerstone of modern vaccine development.
• There is a continuous need for next-generation conjugate vaccines with improved efficacy and targeted immune responses.

Purpose of the Study:

• To develop a controlled method for multi-functionalizing the CRM197 carrier protein.
• To enable site-specific conjugation of carbohydrate-based antigens and immune potentiators to CRM197.
• To enhance vaccine potency through covalent attachment of immune-stimulating molecules.

Main Methods:

• Selective reduction of a single disulfide bond in CRM197.
• Disulfide rebridging using a functionalized dibromopyridazinedione in a one-step procedure.
• Incorporation of functional entities such as TLR7/8 agonists and cyclooctynes into the dibromopyridazinedione.

Main Results:

• Achieved controlled multi-functionalization of CRM197.
• Demonstrated successful site-specific conjugation, preserving T-epitopes.
• Confirmed covalent attachment of immune potentiators for localized cytokine production.

Conclusions:

• The developed method allows for precise and efficient modification of CRM197 for next-generation conjugate vaccines.
• Site-specific conjugation and covalent immune potentiator attachment lead to enhanced immune responses.
• This approach holds significant promise for the development of more effective vaccines.